IRCT201108254166N4已完成未知
Intraocular pressure lowering effect of Lataprost eye drop with once every other day dosing
Tabriz University of MedicalSciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •Inclusion Criteria: 1. Administering eye drop Lataprost % one time at night 2. At least two prior IOP checking in recent month 3. Appropriate IOP control with present medications 4. No prior intraocular surgery
- •Exclusion criteria: 1. Glaucoma surgery 2. Incomplete response to 2 antiglaucoma 3. Not possible to follow-up 4. Corneal problem that interferes with IOP checking 5. Ocular problem except cataract & glaucoma
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Intraocular pressure lowering effect of latanoprost for glaucomatous patients with trabeculectomyPatients with open-angle glaucoma after trabeculectomyJPRN-UMIN000000893Kumamoto University60
已完成
2 期
A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAGOpen-Angle GlaucomaOcular HypertensionNCT01037036Mati Therapeutics Inc.15
已完成
4 期
Evaluation Of Intraocular Pressure Lowering-Effect Of Xalacom In Patients With Poag Or Oh.GlaucomaOcular HypertensionNCT00143208Pfizer's Upjohn has merged with Mylan to form Viatris Inc.250
已完成
4 期
Effect of latanoprost and travoprost ophthalmic solution on corneal epitheliumglaucomaJPRN-UMIN000004000Department of Ophtalmology, University of Tokyo80
尚未招募
不适用
Effect of pressure reducing effect of Ripasudil eye drops in patients with high pressure within the eyeCTRI/2022/09/045191Sankara eye hospital